Dipeptidyl peptidase-4 (DPP4) inhibitor sitagliptin alleviates liver inflammation of diabetic mice by acting as a ROS scavenger and inhibiting the NFκB pathway | Cell Death Discovery
ANTIDIABETIC AGENTS Jiří Slíva. DIABETES MELLITUS Multifactorial disease with genetic component Main symptoms: hyperglycemia, metabolic disturbances Relative. - ppt download
Mechanism of action of DPP-IV inhibitors. | Download Scientific Diagram
DPP4 Inhibitors: How early is appropriate? - ppt download
dpp-4_inhibitors [TUSOM | Pharmwiki]
IJERPH | Free Full-Text | The Role of DPP-4 Inhibitors in the Treatment Algorithm of Type 2 Diabetes Mellitus: When to Select, What to Expect | HTML
The role of dipeptidylpeptidase-4 inhibitors in management of cardiovascular disease in diabetes; focus on linagliptin | Cardiovascular Diabetology | Full Text
Antidiabetic gliptins in combination with G-CSF enhances myocardial function and survival after acute myocardial infarction - International Journal of Cardiology
Gliptins in managing diabetes - Reviewing computational strategy - ScienceDirect
Gliptins
Pleiotropic effects of the dipeptidylpeptidase-4 inhibitors on the cardiovascular system | American Journal of Physiology-Heart and Circulatory Physiology
Mechanism of action of sitagliptin, vildagliptin, and exenatide. GLP-1... | Download Scientific Diagram
Choosing a Gliptin | Semantic Scholar
Mechanism of action for GIP, GLP-1 analogues and DPP4 inhibitors in... | Download Scientific Diagram
Cardiovascular effects of gliptins | Nature Reviews Cardiology
Dipeptidyl Peptidase IV and Its Inhibitors: Therapeutics for Type 2 Diabetes and What Else? | Journal of Medicinal Chemistry
Sitagliptin - First In Class DPP4 Inhibitor for Type 2 Diabetes by sunny Fang - Issuu
Mechanism of action of glucagon-like peptide-1 (GLP-1) receptor... | Download Scientific Diagram
Clinical pharmacology of dipeptidyl peptidase 4 inhibitors indicated for the treatment of type 2 diabetes mellitus - Chen - 2015 - Clinical and Experimental Pharmacology and Physiology - Wiley Online Library
Teneligliptin in management of type 2 diabetes mellitus | DMSO
DPP-4 inhibitors
Cardiovascular effects of gliptins | Semantic Scholar
Vildagliptin
DPP-4 inhibition and COVID-19: From initial concerns to recent expectations - ScienceDirect